Translational Research Institute Australia Revenue and Competitors

Woolloongabba, Australia

Location

N/A

Total Funding

Research

Industry

Estimated Revenue & Valuation

  • Translational Research Institute Australia's estimated annual revenue is currently $20.2M per year.(i)
  • Translational Research Institute Australia's estimated revenue per employee is $112,200

Employee Data

  • Translational Research Institute Australia has 180 Employees.(i)
  • Translational Research Institute Australia grew their employee count by 15% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$8.8M866%$443.3MN/A
#2
$11.6M1146%N/AN/A
#3
$9.5M9333%N/AN/A
#4
$31.9M28427%N/AN/A
#5
$5M542%N/AN/A
#6
$4M4948%N/AN/A
#7
$3M370%N/AN/A
#8
$19.3M17213%N/AN/A
#9
$5.3M5826%N/AN/A
#10
$67.4M5297%N/AN/A
Add Company

The TRI is a medical research institute based in Brisbane, Australia, interfacing directly with hospital clinicians, government and industry to improve the success of scientific discoveries translated into real treatments and diagnostics for improved health outcomes.

keywords:N/A

N/A

Total Funding

180

Number of Employees

$20.2M

Revenue (est)

15%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Translational Research Institute Australia News

2022-04-17 - RELATIVITY-047 Update: Novel Immunotherapy Duo Delays ...

... PhD, of the Melanoma Institute Australia, The University of Sydney, ... Chair of Melanoma Medical Oncology and Translational Research.

2022-04-06 - Hope for stroke? Protein could limit damage by shielding parts ...

The research team, which included scientists from Germany's University of Tübingen and Australia's Murdoch Children's Research Institute, used...

2022-03-30 - Clear, evidence-based guidelines needed for NAFLD in type 2 ...

... for Liver Disease Research in the Translational Research Institute at ... in three primary care and one hospital setting in Australia.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$57M19212%N/A
#2
$15M21911%N/A